Protecting Your Pathology: Cybersecurity for Digital Workflows
Digital pathology opens up new cybersecurity risks for labs—but simple steps can mitigate those risks and increase digital resilience
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
Expert Q&A: Harnessing the Power of AI
AI could help pathologists manage increasing workloads amid staffing shortages—if only they take the leap.
Surviving a Cyberattack
When it comes to cyberattacks, the threat is “when,” not “if”—and labs must be prepared to mitigate, contain, and recover from breaches
Biomarkers Personalize PSA Screening
From - Diagnostic Testing & Emerging Technologies
Early diagnosis of prostate cancer (PCa) is marred by a lack of consensus on the best screening strategy. Prostate specific antigen (PSA) had been…
iSpecimen Generates New Market for Discarded Biospecimens
From - Diagnostic Testing & Emerging Technologies
iSpecimen (Lexington, Mass.) can be thought of as a cross between a dating site and an online marketplace for human biospecimens. The company has built…
Do No Harm: Diagnostic Errors and the Lab
By Jennifer (McMahon) Dawson, MHA, DLM (ASCP) bio
"Do no harm" is the mantra that health care providers live by. Doctors, nurses and laboratory professionals alike enter into the business of health care because they are motivated to…
Blood Test Could Improve CAD Diagnosis
From - Diagnostic Testing & Emerging Technologies
A simple blood test can accurately, noninvasively, and quickly diagnose heart disease, according to a study published in the…
Genomic Markers May ID Risk of Chemo Side Effects
From - Diagnostic Testing & Emerging Technologies
While much attention is focused on using genomic markers to target the effectiveness of treatments, simultaneous research is exploring use of genomic markers to…
Screening Test Use Up After ACA
From - Diagnostic Testing & Emerging Technologies
There was an uptick in preventive screening after enactment of the Affordable Care Act (ACA), yet cancer-screening rates in the United States remain below…
